Reducing the risk of infection in a patient who will undergo splenectomy
2012; Canadian Medical Association; Volume: 184; Issue: 9 Linguagem: Inglês
10.1503/cmaj.120159
ISSN1488-2329
AutoresDan Petrescu, Wayne L. Gold, Jerome A. Leis,
Tópico(s)Myeloproliferative Neoplasms: Diagnosis and Treatment
ResumoA 28-year-old woman with steroid-refractory immune thrombocytopenia (platelet count 16 × 109/L, with associated epistaxis) recently saw her hematologist, who recommended elective splenectomy for the management of her condition.[1][1] After a discussion with her hematologist, the patient has ongoing
Referência(s)